Adient (ADNT) Stock Price, News & Analysis

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Adient in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ADNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ADNT, but not buy additional shares or sell existing shares.
View ADNT analyst ratings or view top-rated stocks.

8 brokers have issued 1 year price targets for Adient's stock. Their ADNT share price targets range from $35.00 to $62.00. On average, they expect the company's stock price to reach $42.86 in the next year. This suggests a possible upside of 52.5% from the stock's current price.
View analysts price targets for ADNT or view top-rated stocks among Wall Street analysts.

Adient's stock was trading at $36.36 at the start of the year. Since then, ADNT shares have decreased by 22.7% and is now trading at $28.11.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024.
View our ADNT earnings forecast.

Adient will be holding an earnings conference call on Friday, May 3rd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Adient plc (NYSE:ADNT) posted its quarterly earnings data on Wednesday, February, 7th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.47 by $0.16. The company earned $3.70 billion during the quarter, compared to analyst estimates of $3.76 billion. Adient had a trailing twelve-month return on equity of 7.90% and a net margin of 1.39%. The business's quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.34 earnings per share.

ETFs with the largest weight of Adient (NYSE:ADNT) stock in their portfolio include Invesco S&P MidCap 400 Pure Value ETF (RFV), Fidelity Electric Vehicles and Future Transportation ETF (FDRV), Invesco S&P MidCap Value with Momentum ETF (XMVM), Invesco S&P MidCap 400 Revenue ETF (RWK) and Dimensional US Small Cap Value ETF (DFSV).iShares Self-Driving EV and Tech ETF (IDRV).

Adient updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $15.4 billion-$15.5 billion, compared to the consensus revenue estimate of $15.6 billion.

100 employees have rated Adient Chief Executive Officer Douglas G. DelGrosso on Glassdoor.com. Douglas G. DelGrosso has an approval rating of 77% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), Exxon Mobil (XOM), Cisco Systems (CSCO), AbbVie (ABBV), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Ford Motor (F) and Johnson & Johnson (JNJ).

Adient's stock is owned by a number of institutional and retail investors. Top institutional investors include Executive Wealth Group LLC (0.12%) and First Hawaiian Bank (0.03%). Insiders that own company stock include Douglas G Delgrosso, Gregory Scott Smith, Heather M Tiltmann, James Conklin, Jeffrey Stafeil, Jerome J Dorlack, Michel Pierre Rose Berthelin and Peter Carlin.
View institutional ownership trends.

Shares of ADNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.